MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

30 May 2022 Evaluate
Net sales declined -29.82%  to  Rs. 28871.70 million from Rs. 41140.30 millions.Net profit declined -8.07% to Rs. 8021.60 millions from Rs. 8725.80 millions.Operating profit for the quarter ended March 2022 decreased to 9203.40 millions as compared to 12434.50 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 28871.70 41140.30 -29.82 112871.40 158236.80 -28.67 112871.40 158236.80 -28.67
Other Income 4133.70 2674.20 54.58 6709.90 5898.60 13.75 6709.90 5898.60 13.75
PBIDT 9203.40 12434.50 -25.98 21443.90 47096.90 -54.47 21443.90 47096.90 -54.47
Interest 49.10 59.30 -17.20 169.40 286.80 -40.93 169.40 286.80 -40.93
PBDT 8407.20 12375.20 -32.06 20527.40 46810.10 -56.15 20527.40 46810.10 -56.15
Depreciation 1012.20 1240.70 -18.42 4152.60 4880.00 -14.91 4152.60 4880.00 -14.91
PBT 7395.00 11134.50 -33.58 16374.80 41930.10 -60.95 16374.80 41930.10 -60.95
TAX -626.60 2408.70 -126.01 1827.70 10801.00 -83.08 1827.70 10801.00 -83.08
Deferred Tax -880.70 318.90 -376.17 -1969.30 367.60 -635.72 -1969.30 367.60 -635.72
PAT 8021.60 8725.80 -8.07 14547.10 31129.10 -53.27 14547.10 31129.10 -53.27
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 31.88 30.22 5.47 19.00 29.76 -36.17 19.00 29.76 -36.17
Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..